Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Gastroenterology. 2017 May;152(6):1629-1630. doi: 10.1053/j.gastro.2016.09.068. Epub 2017 Apr 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diarrhea
  • Humans
  • Irritable Bowel Syndrome*
  • Rifamycins*
  • Rifaximin

Substances

  • Rifamycins
  • Rifaximin